New journal focused on Huntington's disease (HD)

News

New journal focused on Huntington's disease (HD)

CMMT NEWS RELEASE

We are delighted to announce the forthcoming launch of the Journal of Huntington's Disease (JHD). Available in both online and print formats in 2012, this new high-quality journal will focus on Huntington's disease and related disorders.

Under the leadership of Dr. Blair Leavitt, JHD will bring together original research in basic science, translational research and clinical medicine to help expedite fundamental understanding and improve treatment of HD and related disorders.

JHD is currently accepting submissions. Read more.


Share this:

The Centre for Molecular Medicine and Therapeutics (CMMT) is a synergistic group of scientists and researchers who share a strong sense of commitment to solve the many genetic questions surrounding human illness and well being. Affiliated with the University of British Columbia and the Child & Family Research Institute, CMMT conducts discovery research and translates that research into effective clinical and therapeutic strategies to promote health. For more information, visit http://www.cmmt.ubc.ca/.

For more information, please contact Nicki Kahnamoui.